P650: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BTK DEGRADER, IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL MALIGNANCIES

Bibliographic Details
Main Authors:	K. Linton, G. P. Collins, D. El-Sharkawi, R. Mous, F. Forconi, M. Tan, S. Nandakumar, E. Meredith, K. L. Jameson, S. G. Injac, J. Doorduijn
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000845484.57038.64

Internet